Nilotinib
150 mg · Capsule
- Prescription only
- Kinase Inhibitor
- Active substance
- Nilotinib
- Made by
- Cipla USA Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria5 matching products
European UnionNo exact match for this strength and form
Spain7 matching products
France2 matching products
Details
| Made by | Cipla USA Inc. |
|---|---|
| Active substance | Nilotinib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 150 mg |
| Form | Capsule |
| Route | Oral |
| Packs | 4 CARTON in 1 CARTON / 4 BLISTER PACK in 1 CARTON / 7 CAPSULE in 1 BLISTER PACK · 4 CARTON in 1 CARTON / 2 BLISTER PACK in 1 CARTON / 14 CAPSULE in 1 BLISTER PACK |
| NDC | 69097-031 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
21 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Capsule21 products
150 mg8
150 mg · 8 companies
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.